The impact of product information and trials on demand for smokeless tobacco and cigarettes: evidence from experimental auctions.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 24321456.
- Also identified by DOI 10.1016/j.ypmed.2013.11.001 and PMC identifier 4309363.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Epidemiological and toxicological evidence suggests lower risk of smokeless tobacco (ST) products compared to cigarettes. Less is known, however, about consumer perceptions and use of novel forms of ST, including snus and dissolvable tobacco. In this study, we conducted in-person experimental auctions in Buffalo, NY, Columbia, SC, and Selinsgrove, PA with 571 smokers to test the impact of information and product trials on smokers' preferences. Auctions were conducted between November 2010-November 2011. We found no evidence of an impact of product trials on demand in our auctions. Anti-ST information increased demand for cigarettes when presented alone, but when presented with pro-ST information it decreased demand for cigarettes. It did not decrease demand for ST products. Anti-smoking information increased demand for ST products, but did not affect cigarette demand. These findings suggest that credible and effective communications about tobacco harm reduction should reinforce the negative effects of smoking.
Medical subject headings
- Competitive Bidding
- Health Education
- Product Labeling
- Smoking
- Tobacco Use Cessation Devices
- Tobacco, Smokeless